SMFM’s 2021 Virtual Annual Pregnancy Meeting: Featuring Laura Riley, MD
Contemporary OB/GYN’s Editorial Advisory Board member, Laura Riley, MD, will participate in several virtual events at SMFM’s 2021 Virtual Annual Pregnancy Meeting.
The Society for Maternal-Fetal Medicine’s 2021 Virtual Annual Meeting will be held from Jan. 25 to Jan. 30. For more information and registration details, visit SMFM.org.
Riley is Chair of Obstetrics and Gynecology at Weill Cornell Medicine, and Obstetrician- and Gynecologist-in-Chief at New York Presbyterian Hospital in New York City, NY.
Stay up to date with Riley’s latest research with the schedule below:
Monday, January 25, 2021
3 p.m. to 5 p.m. EST
Womxn’s Health Collaborative Symposium: Crucial conversations for Careers in MFM
Thursday, January 28, 2021
12:15 p.m. to 12:30 p.m. EST
Augmenting/Replacing Obstetric Comorbidity Index with Labor & Delivery Features Improves Prediction of Severe Maternal Morbidity
Friday, January 29, 2021
11:15 a.m. to 11:30 a.m. EST
Influenza in pregnancy and sever maternal morbidity in the United States, 2000-2015
Saturday, January 30, 2021
10:30 a.m. to 1 p.m. EST
Oral Concurrent Session 9-Infectious Diseases
10:30 a.m. to 10:45 a.m.
89-Association of chronic comorbid disease and severe maternal morbidity among pregnant patients with influenza
For more information, visit the Society for Maternal-Fetal Medicine.
Contemporary OB/GYN Senior Editor Angie DeRosa gets insight on the current state of COVID-19 from Christina Han, MD, division director of maternal-fetal medicine at the University of California, Los Angeles, and member of its COVID-19 task force. Han is an active member of the Society for Maternal-Fetal Medicine and discusses the issues on behalf of SMFM.
Listen
Exogenous hormones and patients at increased risk for breast cancer
October 17th 2023This lecture, presented by Holly J. Pederson, MD, at The Menopause Society 2023 Annual Meeting, looked at combined oral contraceptives in BRCA carriers and other high-risk patients, and hormone therapy in postmenopausal gene carriers as well as other high-risk women.
Read More
